Acyclovir

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 54348-624
  • Package NDC 54348-624-10
  • Application number ANDA203834
  • SPL ID ea935f93-6c2c-2e8a-e053-2995a90a2ce0
  • SPL set ID d824fc07-9f03-4cb2-9bf8-ff7cc2955255
  • UNII X4HES1O11F
  • RxCUI 197313

What the source publishes

Labeler
PharmPak, Inc.
Active ingredients
ACYCLOVIR
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:54348-624_ea935f93-6c2c-2e8a-e053-2995a90a2ce0
{
  "name": "Acyclovir",
  "splId": "ea935f93-6c2c-2e8a-e053-2995a90a2ce0",
  "labels": [
    {
      "setId": "d824fc07-9f03-4cb2-9bf8-ff7cc2955255",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d824fc07-9f03-4cb2-9bf8-ff7cc2955255",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d824fc07-9f03-4cb2-9bf8-ff7cc2955255"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "PharmPak, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE in 1 BOX (54348-624-10)  / 10 TABLET in 1 BOTTLE",
      "package_ndc": "54348-624-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190709"
    }
  ],
  "productId": "54348-624_ea935f93-6c2c-2e8a-e053-2995a90a2ce0",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "54348-624",
  "deaSchedule": null,
  "genericName": "ACYCLOVIR",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ACYCLOVIR",
      "strength": "800 mg/1"
    }
  ],
  "applicationNumber": "ANDA203834",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190709",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000020060",
      "N0000180187",
      "N0000180188",
      "N0000175468",
      "N0000175459"
    ],
    "unii": [
      "X4HES1O11F"
    ],
    "rxcui": [
      "197313"
    ],
    "spl_set_id": [
      "d824fc07-9f03-4cb2-9bf8-ff7cc2955255"
    ],
    "pharm_class_epc": [
      "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
      "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
      "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "DNA Polymerase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "PharmPak, Inc."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:54348-624_ea935f93-6c2c-2e8a-e053-2995a90a2ce0"